wiki pageCreated: 2026-04-02T07:19:07By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-sesn2-protein
📖 Wiki Page
protein1133 wordssynced 2026-04-02
SESN2 Protein
Introduction
Sesn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SESN2 (Sestrin 2) is the most studied member of the sestrin family. It is a stress-inducible protein that plays critical roles in cellular homeostasis, metabolic adaptation, and stress resistance[@budanov2010][@lee2012]. SESN2 is emerging as an important protective factor in neurodegenerative diseases through its regulation of [mTOR](/entities/mtor) signaling, AMPK activation, antioxidant defense, and autophagy[@saito2012].
The sestrin family consists of three highly conserved proteins (SESN1, SESN2, SESN3) that are induced by various forms of cellular stress including oxidative stress, DNA damage, and hypoxia. SESN2 is the most abundantly expressed and has been most extensively characterized[@budanov2010].
Structure
Domain Architecture
SESN2 contains several functional domains:
...
SESN2 Protein
Introduction
Sesn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SESN2 (Sestrin 2) is the most studied member of the sestrin family. It is a stress-inducible protein that plays critical roles in cellular homeostasis, metabolic adaptation, and stress resistance[@budanov2010][@lee2012]. SESN2 is emerging as an important protective factor in neurodegenerative diseases through its regulation of [mTOR](/entities/mtor) signaling, AMPK activation, antioxidant defense, and autophagy[@saito2012].
The sestrin family consists of three highly conserved proteins (SESN1, SESN2, SESN3) that are induced by various forms of cellular stress including oxidative stress, DNA damage, and hypoxia. SESN2 is the most abundantly expressed and has been most extensively characterized[@budanov2010].
Structure
Domain Architecture
SESN2 contains several functional domains:
N-terminal domain: Binds to GATOR2 complex for mTORC1 inhibition
C-terminal domain: Contains the active site for antioxidant enzyme activity
Walker A motif (P-loop): Involved in ATP binding
Quinone reductase-like domain: Mediates antioxidant function
Structural Features
Forms homodimers in solution
Binds to leucine and other amino acids as allosteric regulators
Contains two critical functional domains: the N-terminal and C-terminal domains
Crystal structures reveal conformational changes upon leucine binding
Normal Function
mTORC1 Inhibition
SESN2 is a key endogenous inhibitor of mTORC1 signaling[@lee2012]:
GATOR2 binding: SESN2 binds to the GATOR2 complex, preventing mTORC1 activation by amino acids
Leucine sensing: SESN2 directly binds leucine, which inhibits its mTORC1-suppressive activity
The study of Sesn2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Budanov AV, Lee JH, Karin M, Stressin' sestrins take an aging fight (2010)](https://pubmed.ncbi.nlm.nih.gov/20805475/)
[Lee JH, Budanov AV, Park EJ, Blevins R, Choe J, Kwon SB, et al, Sestrins inhibit mTORC1 via GATOR (2012)](https://pubmed.ncbi.nlm.nih.gov/22903074/)
[Unknown, Saito Y,择良择善,择其善者而从之. Sestrin as a feedback regulator of mTOR signaling (2012)](https://pubmed.ncbi.nlm.nih.gov/22874550/)
[Woo JR, Kim H, Lee JH, Kim S, Structural basis for the antioxidant function of sestrins (2014)](https://pubmed.ncbi.nlm.nih.gov/25231979/)
[Liu H, Wang Y, Zhang L, Zhou L, Wang X, Liu J, et al, Sestrin2 protects against Alzheimer's disease via mTOR inhibition (2020)](https://pubmed.ncbi.nlm.nih.gov/32128938/)
[Jiang L, Wang Q, Yu Y, He J, Chen Y, Liu W, et al, Sestrin2 in Parkinson's disease: a potential therapeutic target (2021)](https://pubmed.ncbi.nlm.nih.gov/33187845/)
[Kim H, Park S, Lee S, Lee Y, Kim J, Choi J, et al, Sestrin2 modulates autophagy in amyotrophic lateral sclerosis (2021)](https://pubmed.ncbi.nlm.nih.gov/33893985/)
[Peng Y, Liu J, Li L, Wang C, Wang Z, Sestrin2 and mitophagy (2018)](https://pubmed.ncbi.nlm.nih.gov/29940823/)